2,603 followers
Combination therapy inhibits #glioblastoma tumorigenicity & #CancerStemCell maintenance in vitro, and delays tumor growth & progression in vivo. @NebraskaMed https://t.co/fwf9vYyoYI https://t.co/1PsE9PlfFK
Combination therapy inhibits #glioblastoma tumorigenicity & #CancerStemCell maintenance in vitro, and delays tumor growth & progression in vivo. @NebraskaMed https://t.co/fwf9vYyoYI https://t.co/1PsE9PlfFK
Afatinib and Temozolomide combination inhibits tumorigenesis by targeting EGFRvIII-cMet signaling in glioblastoma cells. https://t.co/7zOkVBpgld